BLACKROCK SMALLER COMPANIES TRUST plc
All information is at 30 September 2010 and unaudited.
Performance at month end is calculated on a capital only basis
One Three One Three Five
Month Months Year Years Years
Net asset value 15.4% 25.9% 38.3% 10.5% 59.4%
Share price 15.3% 23.8% 41.6% 6.4% 52.2%
HGSC ex Inv Trust + AIM* 8.5% 13.5% 15.0% -14.5% 0.2%
Sources: BlackRock and Datastream
*With effect from 1 September 2007 the Hoare Govett Smaller Companies plus AIM
(ex Investment Companies) Index replaced the FTSE SmallCap Index (ex Investment
Companies) as the Company's benchmark. For three year and five year periods the
above index has been blended to reflect this.
At month end
Net asset value Capital only (debt at par value): 494.39p
Net asset value Capital only (debt at fair value): 490.14p
Net asset value incl. Income (debt at par value): 500.60p**
Net asset value incl. Income (debt at fair value): 496.35p**
Share price: 402.25p
Discount to Capital only NAV (debt at par value): 18.6%
Discount to Capital only NAV (debt at fair value): 17.9%
Net yield: 1.2%
Total assets: £260.4m^
Gearing incl. Income: 8.7%
Ordinary shares in issue: 47,879,792^^
**includes net revenue of 6.21p.
^includes current year revenue.
^^excludes 2,113,731 shares held in treasury.
Ten Largest Sector
Weightings % of Total Assets
Industrial Metals & Mining 11.8
Software & Computer Services 10.6
Oil & Gas Producers 10.2
Electronic & Electrical Equipment 8.8
Financial Services 8.1
Support Services 7.4
Industrial Engineering 6.9
Media 5.2
Pharmaceuticals & Biotechnology 4.8
Technology Hardware & Equipment 4.3
----
Total 78.1
====
Ten Largest Equity Investments (in alphabetical order)
Company
Abcam Group
Aveva Group
City of London Investment Group
Domino Printing Sciences
Fidessa group
Hutchison China Meditech
Rotork
Spirax-Sarco Engineering
Victrex
Western Coal
Commenting on the markets, Mike Prentis, representing the Investment Manager
noted:
September was a very strong month for equities as markets took the view that a
double dip recession was increasingly unlikely. During September, the Company's
NAV per share rose by 15.4% in capital only terms; this was substantially ahead
of the benchmark which rose by 8.5%. The FTSE 100 Index rose by 6.2%.
Our outperformance was derived from stock selection, the majority of our
outperformance, asset allocation and gearing, which accounted for about 0.9% of
the outperformance.
From a stock point of view our relative outperformance was driven by a wide
range of stocks; six holdings contributed more than 0.25% each to relative
outperformance, but the largest contributed only 0.42%. The holdings were
Western Coal, Encore Oil, IQE, Oxford Instruments, Avocet Mining and Eastern
Platinum. Western Coal increased production guidance in early October and
arranged an analyst visit; the shares moved up ahead of the visit, in
expectation of good news. Having drilled the Catcher well in the North Sea and
discovered light oil, which is increasingly looking like one of the largest oil
discoveries in the North Sea in recent years, Encore Oil also drilled an
appraisal well on the Cladhan prospect; this too was successful and is very
material. Compound semiconductor wafer manufacturer IQE made a small
acquisition and confirmed it was trading very well. Oxford Instruments AGM
statement pointed to sustained strengthening of demand in its industrial
division; its house broker increased current year earnings estimates by 33%.
Avocet benefited from the higher gold price and a 16% increase in its resource
base at its Inata mine. Eastern Platinum benefited from the recovery in the
platinum price.
Pleasingly, there was only one poor individual stock, Hutchison China Meditech,
which contributed -0.26% to relative performance. This was not a reflection on
trading but just a quiet period for newsflow following a strong run in the
shares. We remain excited about the long term prospects for this company.
From a sector point of view, our overweight positions in the mining and
electronic & electricals sectors served us well. Unsurprisingly, during a
strong month for markets, our underweight position in food producers also
contributed well.
We sold holdings in two retailers, Halfords and Mothercare. Halfords had
experienced problems with a new distribution centre; Mothercare has been seeing
softer UK trading and we took the view the premium rating was likely to slip.
We also sold our holding in Chaucer, a Lloyds insurer. Pricing trends are not
favouring these companies at present.
We took new holdings in BlueBay Asset Management and Elementis. BlueBay is a
leading specialist manager of fixed income credit. Net fund inflows have been
good and the opportunity in emerging market bonds, among others, looks
attractive. Elementis is a global manufacturer of additives that enhance the
feel, flow and finish of everyday products. Its trading has strengthened
materially, has good growth opportunities, and the valuation remains
attractive.
Latest information is available by typing www.blackrock.co.uk/its on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal).
15 October 2010
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.